nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Irinotecan—colon cancer	0.0433	0.384	CbGbCtD
Nimodipine—CYP3A5—Vincristine—colon cancer	0.0379	0.336	CbGbCtD
Nimodipine—CYP3A4—Irinotecan—colon cancer	0.0169	0.15	CbGbCtD
Nimodipine—CYP3A4—Vincristine—colon cancer	0.0148	0.131	CbGbCtD
Nimodipine—Vasospasm—Capecitabine—colon cancer	0.0127	0.0356	CcSEcCtD
Nimodipine—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.0106	0.0296	CcSEcCtD
Nimodipine—CACNB4—vagina—colon cancer	0.0102	0.0657	CbGeAlD
Nimodipine—Ileus—Vincristine—colon cancer	0.00943	0.0264	CcSEcCtD
Nimodipine—Ileus—Irinotecan—colon cancer	0.00919	0.0257	CcSEcCtD
Nimodipine—CACNB3—digestive system—colon cancer	0.00883	0.057	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—colon cancer	0.00829	0.0534	CbGeAlD
Nimodipine—CACNB3—vagina—colon cancer	0.0078	0.0503	CbGeAlD
Nimodipine—Platelet count decreased—Capecitabine—colon cancer	0.00732	0.0204	CcSEcCtD
Nimodipine—Deep vein thrombosis—Capecitabine—colon cancer	0.00715	0.02	CcSEcCtD
Nimodipine—Haematoma—Capecitabine—colon cancer	0.00692	0.0193	CcSEcCtD
Nimodipine—AHR—digestive system—colon cancer	0.00654	0.0422	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Irinotecan—colon cancer	0.0065	0.0182	CcSEcCtD
Nimodipine—Ileus—Capecitabine—colon cancer	0.00615	0.0172	CcSEcCtD
Nimodipine—CACNA1C—smooth muscle tissue—colon cancer	0.00606	0.0391	CbGeAlD
Nimodipine—AHR—bone marrow—colon cancer	0.00603	0.0389	CbGeAlD
Nimodipine—CACNB2—digestive system—colon cancer	0.00593	0.0383	CbGeAlD
Nimodipine—AHR—vagina—colon cancer	0.00578	0.0373	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—colon cancer	0.00552	0.0356	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00543	0.0152	CcSEcCtD
Nimodipine—Deep vein thrombosis—Methotrexate—colon cancer	0.00533	0.0149	CcSEcCtD
Nimodipine—NR3C2—renal system—colon cancer	0.00531	0.0343	CbGeAlD
Nimodipine—CACNB1—lymph node—colon cancer	0.00526	0.0339	CbGeAlD
Nimodipine—CACNB2—vagina—colon cancer	0.00524	0.0338	CbGeAlD
Nimodipine—CACNB3—lymph node—colon cancer	0.00504	0.0325	CbGeAlD
Nimodipine—AHR—liver—colon cancer	0.00487	0.0314	CbGeAlD
Nimodipine—Hyponatraemia—Vincristine—colon cancer	0.00487	0.0136	CcSEcCtD
Nimodipine—CACNA1C—digestive system—colon cancer	0.00479	0.0309	CbGeAlD
Nimodipine—Hyponatraemia—Irinotecan—colon cancer	0.00474	0.0132	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00472	0.0132	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00452	0.0126	CcSEcCtD
Nimodipine—CACNB2—liver—colon cancer	0.00442	0.0285	CbGeAlD
Nimodipine—NR3C2—digestive system—colon cancer	0.00436	0.0281	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00435	0.0122	CcSEcCtD
Nimodipine—Cramp muscle—Irinotecan—colon cancer	0.00425	0.0119	CcSEcCtD
Nimodipine—CACNA1C—vagina—colon cancer	0.00423	0.0273	CbGeAlD
Nimodipine—Fluid retention—Capecitabine—colon cancer	0.00413	0.0115	CcSEcCtD
Nimodipine—Sweating increased—Irinotecan—colon cancer	0.00397	0.0111	CcSEcCtD
Nimodipine—CACNA1D—liver—colon cancer	0.00386	0.0249	CbGeAlD
Nimodipine—NR3C2—vagina—colon cancer	0.00385	0.0248	CbGeAlD
Nimodipine—AHR—lymph node—colon cancer	0.00374	0.0241	CbGeAlD
Nimodipine—Depression—Vincristine—colon cancer	0.00372	0.0104	CcSEcCtD
Nimodipine—Phlebitis—Capecitabine—colon cancer	0.00367	0.0102	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00363	0.0101	CcSEcCtD
Nimodipine—Jaundice—Irinotecan—colon cancer	0.00355	0.00991	CcSEcCtD
Nimodipine—CACNB2—lymph node—colon cancer	0.00339	0.0219	CbGeAlD
Nimodipine—Bradycardia—Irinotecan—colon cancer	0.00332	0.00929	CcSEcCtD
Nimodipine—NR3C2—liver—colon cancer	0.00325	0.0209	CbGeAlD
Nimodipine—Hyponatraemia—Capecitabine—colon cancer	0.00317	0.00886	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00316	0.00883	CcSEcCtD
Nimodipine—Cardiac disorder—Vincristine—colon cancer	0.00311	0.00869	CcSEcCtD
Nimodipine—Angiopathy—Vincristine—colon cancer	0.00304	0.0085	CcSEcCtD
Nimodipine—Cardiac disorder—Irinotecan—colon cancer	0.00303	0.00847	CcSEcCtD
Nimodipine—Flushing—Irinotecan—colon cancer	0.00303	0.00847	CcSEcCtD
Nimodipine—Angiopathy—Irinotecan—colon cancer	0.00296	0.00828	CcSEcCtD
Nimodipine—CACNA1D—lymph node—colon cancer	0.00296	0.0191	CbGeAlD
Nimodipine—Immune system disorder—Irinotecan—colon cancer	0.00295	0.00824	CcSEcCtD
Nimodipine—Liver function test abnormal—Capecitabine—colon cancer	0.00292	0.00815	CcSEcCtD
Nimodipine—CYP3A5—renal system—colon cancer	0.00287	0.0185	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00279	0.00778	CcSEcCtD
Nimodipine—CACNA1C—lymph node—colon cancer	0.00273	0.0176	CbGeAlD
Nimodipine—Muscle spasms—Irinotecan—colon cancer	0.00273	0.00763	CcSEcCtD
Nimodipine—Anaemia—Vincristine—colon cancer	0.0027	0.00754	CcSEcCtD
Nimodipine—Sweating increased—Capecitabine—colon cancer	0.00266	0.00743	CcSEcCtD
Nimodipine—Anaemia—Irinotecan—colon cancer	0.00263	0.00734	CcSEcCtD
Nimodipine—Hypertension—Vincristine—colon cancer	0.00252	0.00704	CcSEcCtD
Nimodipine—Anaemia—Fluorouracil—colon cancer	0.00252	0.00703	CcSEcCtD
Nimodipine—NR3C2—lymph node—colon cancer	0.00249	0.0161	CbGeAlD
Nimodipine—Myalgia—Vincristine—colon cancer	0.00249	0.00694	CcSEcCtD
Nimodipine—Hypertension—Irinotecan—colon cancer	0.00245	0.00686	CcSEcCtD
Nimodipine—Depression—Capecitabine—colon cancer	0.00243	0.00678	CcSEcCtD
Nimodipine—Oedema—Vincristine—colon cancer	0.00238	0.00665	CcSEcCtD
Nimodipine—Jaundice—Capecitabine—colon cancer	0.00237	0.00663	CcSEcCtD
Nimodipine—CYP3A5—digestive system—colon cancer	0.00236	0.0152	CbGeAlD
Nimodipine—Nervous system disorder—Vincristine—colon cancer	0.00234	0.00653	CcSEcCtD
Nimodipine—Thrombocytopenia—Vincristine—colon cancer	0.00233	0.00652	CcSEcCtD
Nimodipine—Oedema—Irinotecan—colon cancer	0.00232	0.00648	CcSEcCtD
Nimodipine—Myalgia—Fluorouracil—colon cancer	0.00232	0.00648	CcSEcCtD
Nimodipine—Hyperhidrosis—Vincristine—colon cancer	0.0023	0.00643	CcSEcCtD
Nimodipine—Hepatobiliary disease—Capecitabine—colon cancer	0.0023	0.00643	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—colon cancer	0.0023	0.203	CrCbGaD
Nimodipine—Nervous system disorder—Irinotecan—colon cancer	0.00228	0.00636	CcSEcCtD
Nimodipine—Thrombocytopenia—Irinotecan—colon cancer	0.00227	0.00635	CcSEcCtD
Nimodipine—Hyperhidrosis—Irinotecan—colon cancer	0.00224	0.00627	CcSEcCtD
Nimodipine—Hypotension—Vincristine—colon cancer	0.00223	0.00622	CcSEcCtD
Nimodipine—Bradycardia—Capecitabine—colon cancer	0.00223	0.00622	CcSEcCtD
Nimodipine—Oedema—Fluorouracil—colon cancer	0.00222	0.00621	CcSEcCtD
Nimodipine—Hepatitis—Capecitabine—colon cancer	0.00219	0.00611	CcSEcCtD
Nimodipine—Nervous system disorder—Fluorouracil—colon cancer	0.00218	0.00609	CcSEcCtD
Nimodipine—Thrombocytopenia—Fluorouracil—colon cancer	0.00218	0.00608	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—colon cancer	0.00217	0.00607	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00217	0.00606	CcSEcCtD
Nimodipine—Tachycardia—Fluorouracil—colon cancer	0.00217	0.00606	CcSEcCtD
Nimodipine—Hypotension—Irinotecan—colon cancer	0.00217	0.00606	CcSEcCtD
Nimodipine—CYP3A4—renal system—colon cancer	0.00216	0.0139	CbGeAlD
Nimodipine—Nitrendipine—ABCB1—colon cancer	0.00215	0.19	CrCbGaD
Nimodipine—CYP3A5—vagina—colon cancer	0.00208	0.0134	CbGeAlD
Nimodipine—Hypotension—Fluorouracil—colon cancer	0.00208	0.0058	CcSEcCtD
Nimodipine—Dyspnoea—Irinotecan—colon cancer	0.00207	0.00578	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Vincristine—colon cancer	0.00206	0.00575	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—colon cancer	0.00203	0.00567	CcSEcCtD
Nimodipine—Flushing—Capecitabine—colon cancer	0.00203	0.00567	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00202	0.00566	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Irinotecan—colon cancer	0.002	0.0056	CcSEcCtD
Nimodipine—Angiopathy—Capecitabine—colon cancer	0.00198	0.00554	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—colon cancer	0.00198	0.00553	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—colon cancer	0.00197	0.00551	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00192	0.00536	CcSEcCtD
Nimodipine—Amlodipine—ABCB1—colon cancer	0.00185	0.164	CrCbGaD
Nimodipine—Muscle spasms—Capecitabine—colon cancer	0.00183	0.00511	CcSEcCtD
Nimodipine—Depression—Methotrexate—colon cancer	0.00181	0.00505	CcSEcCtD
Nimodipine—CYP3A4—digestive system—colon cancer	0.00177	0.0114	CbGeAlD
Nimodipine—Anaemia—Capecitabine—colon cancer	0.00176	0.00491	CcSEcCtD
Nimodipine—Hypersensitivity—Vincristine—colon cancer	0.00176	0.0049	CcSEcCtD
Nimodipine—CYP3A5—liver—colon cancer	0.00175	0.0113	CbGeAlD
Nimodipine—Hepatobiliary disease—Methotrexate—colon cancer	0.00171	0.00479	CcSEcCtD
Nimodipine—Hypersensitivity—Irinotecan—colon cancer	0.00171	0.00478	CcSEcCtD
Nimodipine—Felodipine—ABCB1—colon cancer	0.00171	0.151	CrCbGaD
Nimodipine—Palpitations—Capecitabine—colon cancer	0.00168	0.0047	CcSEcCtD
Nimodipine—Nifedipine—ABCB1—colon cancer	0.00165	0.147	CrCbGaD
Nimodipine—Hypertension—Capecitabine—colon cancer	0.00164	0.00459	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—colon cancer	0.00164	0.00457	CcSEcCtD
Nimodipine—Diarrhoea—Vincristine—colon cancer	0.00163	0.00455	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—colon cancer	0.00163	0.144	CrCbGaD
Nimodipine—Hepatitis—Methotrexate—colon cancer	0.00163	0.00455	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—colon cancer	0.00162	0.00452	CcSEcCtD
Nimodipine—Diarrhoea—Irinotecan—colon cancer	0.00159	0.00443	CcSEcCtD
Nimodipine—Dizziness—Vincristine—colon cancer	0.00158	0.0044	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—colon cancer	0.00157	0.00439	CcSEcCtD
Nimodipine—Oedema—Capecitabine—colon cancer	0.00155	0.00434	CcSEcCtD
Nimodipine—Dizziness—Irinotecan—colon cancer	0.00153	0.00429	CcSEcCtD
Nimodipine—Nervous system disorder—Capecitabine—colon cancer	0.00152	0.00425	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—colon cancer	0.00152	0.00425	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—colon cancer	0.00152	0.00425	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—colon cancer	0.00152	0.00423	CcSEcCtD
Nimodipine—Vomiting—Vincristine—colon cancer	0.00151	0.00423	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—colon cancer	0.00151	0.00422	CcSEcCtD
Nimodipine—Rash—Vincristine—colon cancer	0.0015	0.0042	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—colon cancer	0.0015	0.00419	CcSEcCtD
Nimodipine—Dermatitis—Vincristine—colon cancer	0.0015	0.00419	CcSEcCtD
Nimodipine—Headache—Vincristine—colon cancer	0.00149	0.00417	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—colon cancer	0.00148	0.00412	CcSEcCtD
Nimodipine—Vomiting—Irinotecan—colon cancer	0.00148	0.00412	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—colon cancer	0.00147	0.00411	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—colon cancer	0.00147	0.0041	CcSEcCtD
Nimodipine—Rash—Irinotecan—colon cancer	0.00146	0.00409	CcSEcCtD
Nimodipine—Dermatitis—Irinotecan—colon cancer	0.00146	0.00408	CcSEcCtD
Nimodipine—Headache—Irinotecan—colon cancer	0.00145	0.00406	CcSEcCtD
Nimodipine—Hypotension—Capecitabine—colon cancer	0.00145	0.00405	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—SRC—colon cancer	0.00144	0.00397	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—HNF4A—colon cancer	0.00143	0.00394	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.00142	0.00392	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA7—colon cancer	0.00142	0.00391	CbGpPWpGaD
Nimodipine—Nausea—Vincristine—colon cancer	0.00142	0.00395	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00141	0.00395	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—colon cancer	0.00141	0.00395	CcSEcCtD
Nimodipine—CACNB3—Metabolism—ODC1—colon cancer	0.00141	0.00388	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CHST5—colon cancer	0.00141	0.00388	CbGpPWpGaD
Nimodipine—Rash—Fluorouracil—colon cancer	0.0014	0.00391	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—colon cancer	0.0014	0.00391	CcSEcCtD
Nimodipine—Headache—Fluorouracil—colon cancer	0.00139	0.00389	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—colon cancer	0.00139	0.00382	CbGpPWpGaD
Nimodipine—Dyspnoea—Capecitabine—colon cancer	0.00138	0.00387	CcSEcCtD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.00138	0.00381	CbGpPWpGaD
Nimodipine—Nausea—Irinotecan—colon cancer	0.00138	0.00385	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.00135	0.00372	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA7—colon cancer	0.00134	0.0037	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00134	0.00374	CcSEcCtD
Nimodipine—AHR—Adipogenesis—TGFB1—colon cancer	0.00132	0.00365	CbGpPWpGaD
Nimodipine—Nausea—Fluorouracil—colon cancer	0.00132	0.00369	CcSEcCtD
Nimodipine—CYP3A4—liver—colon cancer	0.00132	0.00849	CbGeAlD
Nimodipine—Anaemia—Methotrexate—colon cancer	0.00131	0.00366	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—BRAF—colon cancer	0.0013	0.0036	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.00128	0.00353	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—colon cancer	0.00128	0.00352	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—BRAF—colon cancer	0.00127	0.0035	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—DCC—colon cancer	0.00127	0.00349	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—DCC—colon cancer	0.00127	0.00349	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—BRAF—colon cancer	0.00125	0.00345	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—SRC—colon cancer	0.00123	0.0034	CbGpPWpGaD
Nimodipine—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.00122	0.00336	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—colon cancer	0.00121	0.00333	CbGpPWpGaD
Nimodipine—Myalgia—Methotrexate—colon cancer	0.00121	0.00337	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—KRAS—colon cancer	0.00119	0.00329	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—CASP3—colon cancer	0.00119	0.00328	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—colon cancer	0.00119	0.00327	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA7—colon cancer	0.00118	0.00325	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.00118	0.00324	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—SRC—colon cancer	0.00117	0.00322	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00115	0.00317	CbGpPWpGaD
Nimodipine—Hypersensitivity—Capecitabine—colon cancer	0.00114	0.0032	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—colon cancer	0.00113	0.00317	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—colon cancer	0.00113	0.00316	CcSEcCtD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—colon cancer	0.00112	0.0031	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Methotrexate—colon cancer	0.00112	0.00312	CcSEcCtD
Nimodipine—Pruritus—Capecitabine—colon cancer	0.0011	0.00307	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.00109	0.003	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—DCC—colon cancer	0.00109	0.00299	CbGpPWpGaD
Nimodipine—Hypotension—Methotrexate—colon cancer	0.00108	0.00302	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—EP300—colon cancer	0.00107	0.00296	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HNF4A—colon cancer	0.00107	0.00294	CbGpPWpGaD
Nimodipine—Diarrhoea—Capecitabine—colon cancer	0.00106	0.00297	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—colon cancer	0.00106	0.00293	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00105	0.00294	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—CASP3—colon cancer	0.00105	0.00288	CbGpPWpGaD
Nimodipine—Dyspnoea—Methotrexate—colon cancer	0.00103	0.00288	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—DCC—colon cancer	0.00103	0.00284	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—SRC—colon cancer	0.00103	0.00283	CbGpPWpGaD
Nimodipine—Dizziness—Capecitabine—colon cancer	0.00103	0.00287	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—KRAS—colon cancer	0.00102	0.00282	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.00101	0.00279	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—BRAF—colon cancer	0.001	0.00276	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000998	0.00279	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—colon cancer	0.000988	0.00272	CbGpPWpGaD
Nimodipine—Vomiting—Capecitabine—colon cancer	0.000987	0.00276	CcSEcCtD
Nimodipine—Rash—Capecitabine—colon cancer	0.000979	0.00274	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—colon cancer	0.000978	0.00273	CcSEcCtD
Nimodipine—Headache—Capecitabine—colon cancer	0.000973	0.00272	CcSEcCtD
Nimodipine—CACNB1—Neuronal System—BRAF—colon cancer	0.000973	0.00268	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—colon cancer	0.000968	0.00267	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000967	0.00266	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—colon cancer	0.00094	0.00259	CbGpPWpGaD
Nimodipine—Nausea—Capecitabine—colon cancer	0.000922	0.00258	CcSEcCtD
Nimodipine—CACNB2—Developmental Biology—HNF4A—colon cancer	0.000915	0.00252	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—DCC—colon cancer	0.000904	0.00249	CbGpPWpGaD
Nimodipine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000873	0.00241	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.000869	0.00239	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HNF4A—colon cancer	0.000866	0.00239	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CHST5—colon cancer	0.000859	0.00237	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ODC1—colon cancer	0.000859	0.00237	CbGpPWpGaD
Nimodipine—Hypersensitivity—Methotrexate—colon cancer	0.000852	0.00238	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—colon cancer	0.00085	0.00234	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000848	0.00234	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000831	0.00229	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.000823	0.00227	CbGpPWpGaD
Nimodipine—Pruritus—Methotrexate—colon cancer	0.000818	0.00228	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000816	0.00225	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ODC1—colon cancer	0.000814	0.00224	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CHST5—colon cancer	0.000814	0.00224	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—PPARG—colon cancer	0.000813	0.00224	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—BRAF—colon cancer	0.000797	0.0022	CbGpPWpGaD
Nimodipine—Diarrhoea—Methotrexate—colon cancer	0.000791	0.00221	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—TP53—colon cancer	0.000769	0.00212	CbGpPWpGaD
Nimodipine—Dizziness—Methotrexate—colon cancer	0.000764	0.00214	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—colon cancer	0.000763	0.0021	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HNF4A—colon cancer	0.000761	0.0021	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—HRAS—colon cancer	0.000751	0.00207	CbGpPWpGaD
Nimodipine—Vomiting—Methotrexate—colon cancer	0.000735	0.00205	CcSEcCtD
Nimodipine—Rash—Methotrexate—colon cancer	0.000729	0.00204	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—colon cancer	0.000728	0.00203	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—SRC—colon cancer	0.000725	0.002	CbGpPWpGaD
Nimodipine—Headache—Methotrexate—colon cancer	0.000724	0.00202	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—colon cancer	0.000723	0.00199	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CHST5—colon cancer	0.000715	0.00197	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ODC1—colon cancer	0.000715	0.00197	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—colon cancer	0.000706	0.00195	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—NRAS—colon cancer	0.000697	0.00192	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—HNF4A—colon cancer	0.000687	0.00189	CbGpPWpGaD
Nimodipine—Nausea—Methotrexate—colon cancer	0.000687	0.00192	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—colon cancer	0.00067	0.00185	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PPARG—colon cancer	0.00065	0.00179	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—EGFR—colon cancer	0.000635	0.00175	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PPARG—colon cancer	0.000632	0.00174	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	0.00062	0.00171	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—BRAF—colon cancer	0.000611	0.00168	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—KRAS—colon cancer	0.0006	0.00165	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—HRAS—colon cancer	0.0006	0.00165	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—HRAS—colon cancer	0.000584	0.00161	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—SRC—colon cancer	0.00058	0.0016	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000578	0.00159	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—HRAS—colon cancer	0.000575	0.00158	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CTNNB1—colon cancer	0.000572	0.00158	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—colon cancer	0.000564	0.00156	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—SRC—colon cancer	0.000564	0.00155	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—NRAS—colon cancer	0.000558	0.00154	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—colon cancer	0.000549	0.00151	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—NRAS—colon cancer	0.000542	0.00149	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EP300—colon cancer	0.000532	0.00147	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA7—colon cancer	0.000522	0.00144	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—SRC—colon cancer	0.000517	0.00143	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—colon cancer	0.00051	0.00141	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—colon cancer	0.000508	0.0014	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—colon cancer	0.000504	0.00139	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—NRAS—colon cancer	0.000498	0.00137	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—colon cancer	0.000494	0.00136	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—colon cancer	0.00048	0.00132	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—colon cancer	0.000467	0.00129	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PPARG—colon cancer	0.000463	0.00128	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TGFB1—colon cancer	0.000462	0.00127	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—colon cancer	0.00046	0.00127	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—colon cancer	0.000458	0.00126	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—colon cancer	0.000453	0.00125	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—colon cancer	0.000447	0.00123	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—colon cancer	0.000445	0.00123	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—colon cancer	0.000428	0.00118	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EP300—colon cancer	0.000425	0.00117	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EP300—colon cancer	0.000414	0.00114	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—SRC—colon cancer	0.000414	0.00114	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—SRC—colon cancer	0.000413	0.00114	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—colon cancer	0.000408	0.00112	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—colon cancer	0.000403	0.00111	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SRC—colon cancer	0.000402	0.00111	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—colon cancer	0.000402	0.00111	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NRAS—colon cancer	0.000398	0.0011	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NRAS—colon cancer	0.000397	0.00109	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PPARG—colon cancer	0.000397	0.00109	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—colon cancer	0.000397	0.00109	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—colon cancer	0.000392	0.00108	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NRAS—colon cancer	0.000387	0.00107	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PPARG—colon cancer	0.000376	0.00104	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ABCB1—colon cancer	0.000372	0.00102	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—colon cancer	0.00037	0.00102	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—colon cancer	0.000367	0.00101	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TYMS—colon cancer	0.000365	0.00101	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—colon cancer	0.000364	0.001	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—colon cancer	0.000362	0.000999	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—colon cancer	0.000362	0.000998	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—colon cancer	0.00036	0.000991	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—SRC—colon cancer	0.000354	0.000976	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—colon cancer	0.000353	0.000974	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—colon cancer	0.000353	0.000972	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—colon cancer	0.000345	0.00095	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—colon cancer	0.000342	0.000944	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—colon cancer	0.000342	0.000942	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—colon cancer	0.000341	0.000939	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—SRC—colon cancer	0.000335	0.000924	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—colon cancer	0.000333	0.000918	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—colon cancer	0.00033	0.000911	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—colon cancer	0.000327	0.0009	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—colon cancer	0.000326	0.000899	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—colon cancer	0.000323	0.000889	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—colon cancer	0.000321	0.000886	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ODC1—colon cancer	0.000316	0.000872	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CHST5—colon cancer	0.000316	0.000872	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—colon cancer	0.00031	0.000855	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EP300—colon cancer	0.000303	0.000835	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—colon cancer	0.000298	0.000823	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SRC—colon cancer	0.000295	0.000812	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—SRC—colon cancer	0.000295	0.000812	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—colon cancer	0.000294	0.00081	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—colon cancer	0.000293	0.000808	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—colon cancer	0.000291	0.000802	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—colon cancer	0.000291	0.000801	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—colon cancer	0.000287	0.000791	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—colon cancer	0.000287	0.000791	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—colon cancer	0.000283	0.000781	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—colon cancer	0.000283	0.000781	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—colon cancer	0.000283	0.00078	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—colon cancer	0.000281	0.000774	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—colon cancer	0.000279	0.00077	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—colon cancer	0.000278	0.000765	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—colon cancer	0.000265	0.00073	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—colon cancer	0.000263	0.000726	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EP300—colon cancer	0.00026	0.000716	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—colon cancer	0.000259	0.000713	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—colon cancer	0.000258	0.000712	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—colon cancer	0.000258	0.000712	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—colon cancer	0.000257	0.000708	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SRC—colon cancer	0.000253	0.000696	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—colon cancer	0.00025	0.000689	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—colon cancer	0.000249	0.000687	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—colon cancer	0.000246	0.000678	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EP300—colon cancer	0.000246	0.000678	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—colon cancer	0.000244	0.000672	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—colon cancer	0.000244	0.000672	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—colon cancer	0.000243	0.00067	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA7—colon cancer	0.000243	0.000669	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SRC—colon cancer	0.000239	0.000659	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—colon cancer	0.000236	0.00065	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—colon cancer	0.000233	0.000642	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—colon cancer	0.000233	0.000641	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—colon cancer	0.00023	0.000634	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—colon cancer	0.000227	0.000626	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—colon cancer	0.000226	0.000622	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMS—colon cancer	0.000223	0.000614	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—colon cancer	0.000221	0.00061	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EP300—colon cancer	0.000216	0.000596	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—colon cancer	0.000215	0.000593	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—colon cancer	0.000214	0.000589	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMS—colon cancer	0.000211	0.000582	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—colon cancer	0.00021	0.000579	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—colon cancer	0.00021	0.000578	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—colon cancer	0.000209	0.000577	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—colon cancer	0.000207	0.000572	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—colon cancer	0.000207	0.000571	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—colon cancer	0.000205	0.000564	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—colon cancer	0.000203	0.000561	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—colon cancer	0.000202	0.000557	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—colon cancer	0.000198	0.000546	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—colon cancer	0.000189	0.000521	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—colon cancer	0.000188	0.000518	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—colon cancer	0.000186	0.000511	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—colon cancer	0.000184	0.000508	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—colon cancer	0.000183	0.000505	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—colon cancer	0.000178	0.00049	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—colon cancer	0.000174	0.00048	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—colon cancer	0.00017	0.000469	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—colon cancer	0.000169	0.000466	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—colon cancer	0.000168	0.000464	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—colon cancer	0.000158	0.000435	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—colon cancer	0.000157	0.000433	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—colon cancer	0.00015	0.000412	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—colon cancer	0.000149	0.00041	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—colon cancer	0.000148	0.000408	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CHST5—colon cancer	0.000147	0.000405	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ODC1—colon cancer	0.000147	0.000405	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—colon cancer	0.000131	0.000362	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—colon cancer	0.000131	0.00036	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—colon cancer	0.000125	0.000345	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—colon cancer	0.000124	0.000342	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—colon cancer	0.000118	0.000325	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—colon cancer	0.000118	0.000324	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—colon cancer	0.000103	0.000285	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—colon cancer	0.000103	0.000285	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—colon cancer	0.000102	0.000282	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—colon cancer	9.79e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—colon cancer	8.6e-05	0.000237	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—colon cancer	8.36e-05	0.00023	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—colon cancer	8.21e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—colon cancer	7.64e-05	0.000211	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—colon cancer	7.24e-05	0.0002	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—colon cancer	6.36e-05	0.000175	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—colon cancer	6.24e-05	0.000172	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—colon cancer	5.91e-05	0.000163	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—colon cancer	5.82e-05	0.00016	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—colon cancer	5.2e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—colon cancer	4.58e-05	0.000126	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—colon cancer	3.89e-05	0.000107	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—colon cancer	3.82e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—colon cancer	3.81e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—colon cancer	2.82e-05	7.76e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—colon cancer	2.7e-05	7.45e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—colon cancer	2.3e-05	6.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—colon cancer	2.13e-05	5.86e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—colon cancer	1.77e-05	4.88e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.31e-05	3.61e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—colon cancer	1.07e-05	2.95e-05	CbGpPWpGaD
